Contrave, a Weight Loss Combination Pill, Yields Good Cardiovascular Results

[Nelson Vergel]

Orexigen Therapeutics has announced that encouraging interim results from the Light Study evaluating the cardiovascular risks of combination naltrexone/bupropion, indicated for weight loss in obese patients, have prompted resubmission of a new drug application to the FDA., according to a press release.

http://www.healio.com/endocrinology...pion-interim-data-yield-favorable-cv-outcomes

 

[robs2nd75]

Great sample size for the study. There are generics for both meds so if your physician is willing you can save a great deal of money. Did I mention it works!!!